Kraftigt muterad SARS-CoV-2 variant BA.2.86 inte lika resistent mot antikroppar som man först befarade Karolinska Institutet - 02 Oct 2023 Kraftigt muterad SARS-CoV-2 variant BA.2.86 inte lika resistent mot antikroppar som man först befarade ... More
Ökad risk för 30-dagarsdödlighet vid sjukhusförvärvad sars-cov-2 Läkartidningen - 23 Nov 2023 Ökad risk för 30-dagarsdödlighet vid sjukhusförvärvad sars-cov-2 ... More
Statement on the antigen composition of COVID-19 vaccines World Health Organization (WHO) - 26 Apr 2024 Statement on the antigen composition of COVID-19 vaccines ... More
Luftvägsantikroppar ger ett varaktigt skydd mot sars-cov-2 Karolinska Institutet - 16 Jan 2023 Luftvägsantikroppar ger ett varaktigt skydd mot sars-cov-2 ... More
Quality control in SARS-CoV-2 RBD-Fc vaccine production using LC–MS to confirm strain selection and detect ... Nature - 26 Apr 2024 Quality control in SARS-CoV-2 RBD-Fc vaccine production using LC–MS to confirm strain selection and detect ... ... More
Standard laboratory protocols for SARS-CoV-2 characterisation European Union - 18 Oct 2023 Standard laboratory protocols for SARS-CoV-2 characterisation ... More
The Impact of SARS-CoV-2 on Patients With Lower Urinary Tract Symptoms (LUTS) Cureus - 27 Apr 2024 The Impact of SARS-CoV-2 on Patients With Lower Urinary Tract Symptoms (LUTS) ... More
SARS double-tax warning for South African expats BusinessTech - 27 Apr 2024 SARS double-tax warning for South African expats ... More
Epidemiological Update: Circulation of SARS-CoV-2 and other respiratory viruses in the Americas paho.org - 10 Jan 2024 Epidemiological Update: Circulation of SARS-CoV-2 and other respiratory viruses in the Americas ... More
Potentiellt orsakssamband mellan sars-cov-2 och diabetes Läkartidningen - 05 May 2021 Potentiellt orsakssamband mellan sars-cov-2 och diabetes ... More
Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 World Health Organization (WHO) - 11 Mar 2024 Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 ... More
Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection risk Nature - 25 Apr 2024 Ambient carbon dioxide concentration correlates with SARS-CoV-2 aerostability and infection risk ... More
SARS is coming down hard on taxpayers – but there's some good news for trusts BusinessTech - 24 Apr 2024 SARS is coming down hard on taxpayers – but there's some good news for trusts ... More
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants ... Nature - 27 Apr 2024 Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants ... ... More
Framtida testning för sars-cov-2 – inte bara mer utan smartare Läkartidningen - 26 Nov 2020 Framtida testning för sars-cov-2 – inte bara mer utan smartare ... More
Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in ... Nature - 26 Apr 2024 Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in ... ... More
Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS ... Nature - 22 Apr 2024 Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS ... ... More
Prevalence of persistent SARS-CoV-2 in a large community surveillance study Nature - 21 Feb 2024 Prevalence of persistent SARS-CoV-2 in a large community surveillance study ... More
FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection | Signal ... Nature - 23 Apr 2024 FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection | Signal ... ... More